Abiopharma

Samenvatting: BeOne Medicines maakt de financiële resultaten over het tweede kwartaal van 2026 bekend en geeft een update over de bedrijfsactiviteiten

VSEE attributes changed: Attr: Fin_status D -> N;

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

LEDS attributes changed: Attr: Fin_status D -> N;

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

CNTX attributes changed: Attr: Fin_status N -> D;

Omdia：智慧型手機需求疲軟，推動整新機市場顯示面板出貨量創紀錄成長

Warrants - Listing Confirmation: LISTING OF DAILY LEVERAGE CERTIFICATES (DLCs)

Warrants - Listing Confirmation: Product Listings

Birks Group Announces a Change to Its Board

New SEC Form for ResMed Inc.

Rosen Law Firm Urges Datavault AI Inc. (NASDAQ: DVLT) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Tarsus to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026

INVESTOR NOTICE: Bloom Energy Corporation Investors with Substantial Losses Have Opportunity to Lead the Bloom Energy Class Action Lawsuit - BE